Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Punctal plugs

A technology of punctal plug and tear fluid, which can be used in medical formula, ophthalmic surgery, ophthalmic treatment, etc., and can solve problems such as low efficiency, bleeding, and low concentration

Inactive Publication Date: 2012-05-09
JOHNSON & JOHNSON VISION CARE INC
View PDF9 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Active agents for ophthalmic diseases can be administered orally or by injection, but these routes of administration have the disadvantage that, with oral administration, the concentration of the active agent that reaches the eye is too low to obtain the desired pharmacological effect, And their use can be complicated by significant systemic side effects, while injections pose a risk of eyeball infection, discomfort, bleeding or puncture
[0004] Most ophthalmic active agents are typically delivered topically using eye drops which, while effective in some applications, are ineffective

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Punctal plugs
  • Punctal plugs

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0057] 0.35 to 0.75 mg 2 parts of silicone rubber mixture containing crosslinker and catalyst (from Wacker Silicones, Adrian, Michigan) were injection molded as figure 1 Punctal plugs are shown. The dimensions of the punctal plug are as follows: 1.85 mm overall length, 1.00 mm body length, 1.2 mm diameter or radius for the flange and arrowhead, between 5 and 15 μm off center axis, and 2 to 5 inner diameters of Approx. 0.4mm thread.

[0058] Insertion and removal forces are summarized in Table 1:

[0059] Table 1 :

[0060] cork

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Punctal plugs for delivering therapeutic agents have a body, a portion into which the therapeutic agent is held, a winding about the body, and an enlarged portion or anchor at an end.

Description

Background technique [0001] The present invention relates to devices suitable for delivering substances to one or more of the eye, nose and throat. In particular, the present invention relates to punctal plugs for the delivery of at least one active agent. [0002] Human tears are secreted by the lacrimal glands and travel across the ocular surface to a shallow pool called the lake of tears, which is located where the inner ends of the eyelids meet. From there, tears flow through small holes in each of the upper and lower eyelids (called the upper and lower puncta, respectively), from where they enter the respective upper and lower canaliculi, respectively, and The canaliculus is the tube-like passage that leads to the lacrimal sac. The lacrimal sac is the upper, enlarged portion of the nasolacrimal duct, which drains tears into the nasal system. The active agent can thus be delivered to the nose and throat via the canaliculus leading to the nasolacrimal duct. [0003] Act...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61F9/007
CPCA61F9/00772A61F9/0017A61K9/0051
Inventor V·卢斯特P·K·帕内尔V·麦卡蒂尔B·施万H·沙瓦克
Owner JOHNSON & JOHNSON VISION CARE INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products